Methodological Answer: mt:CoII (Cytochrome c oxidase subunit 2) is a mitochondrial DNA-encoded core subunit of COX, responsible for electron transfer from cytochrome c to the catalytic heme a₃-CuB center. Its structural homology to D. melanogaster COXII includes:
A conserved transmembrane domain critical for proton channeling.
A CuA-binding site (residues 151–229) essential for redox activity .
Key experimental validation steps:
Knockdown (KD) assays: RNAi targeting mt:CoII in D. miranda cell lines reduces COX activity by ~55% (similar to D. melanogaster CG7630 KD models ).
BN-PAGE analysis: Solubilize mitochondria with n-dodecyl-β-D-maltoside (DDM) and assess COX assembly via in-gel activity assays .
Co-immunoprecipitation: Confirm physical interaction with COX4 using HA-tagged mt:CoII constructs .
Methodological Answer: Recombinant mt:CoII is typically expressed in E. coli with a C-terminal His tag (e.g., pProEX HT vector) and purified via immobilized metal affinity chromatography (IMAC).
Critical considerations:
Use protease inhibitors during lysis to prevent degradation of the hydrophobic transmembrane domain.
Validate folding via circular dichroism (CD) spectroscopy or redox activity assays .
Methodological Answer: Discrepancies often arise from post-translational modifications (PTMs) or incomplete membrane integration.
Strategies:
Cryo-EM with nanodiscs: Embed recombinant mt:CoII in lipid bilayers to preserve native conformation .
Molecular dynamics (MD) simulations: Compare predicted (AlphaFold) vs. experimental structures (PDB) using tools like GROMACS .
Mass spectrometry: Identify PTMs (e.g., phosphorylation at Ser-45) that alter electrophoretic mobility .
Example data conflict:
Predicted molecular weight: 25.8 kDa (229 aa).
Methodological Answer: Use a combination of spectroscopic and electrochemical assays:
Troubleshooting:
Avoid O₂ exposure during sample preparation to prevent artificial oxidation.
Methodological Answer:
Site-directed mutagenesis: Introduce patient-derived mutations (e.g., G177S) into recombinant mt:CoII .
Functional complementation: Express mutant mt:CoII in D. miranda COX-deficient models and assess:
Key finding in homologs:
Methodological Context:
Tissue-specific redundancy: mt:CoII knockdown in D. melanogaster neurons causes severe defects, but muscle cells show compensatory upregulation of alternative oxidases (AOX) .
Threshold effect: >70% COX activity loss is required for phenotypic manifestation .
Resolution strategy:
Use tissue-specific drivers (e.g., elav-Gal4 for neurons) to bypass systemic compensation .
Combine RNAi with AOX inhibition (e.g., SHAM) to unmask mt:CoII dependency .